Chronic coinfection with hepatitis B and hepatitis C viruses in an Italian population of HIV-infected patients

Journal of Acquired Immune Deficiency Syndromes

Volumn 44, Issue 5, 2007, Pages 606-607

  Sollima, Salvatore ^a   Caramma, Ilaria ^a   Menzaghi, Barbara ^a   Massetto, Benedetta ^a   Acquaviva, Verónica ^a   Giulani, Giuseppe ^a   Moroni, Mauro ^a   Antinori, Spinello ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EMTRICITABINE; LAMIVUDINE; PEGINTERFERON ALPHA2B; RIBAVIRIN; TENOFOVIR DISOPROXIL;

ALCOHOL ABUSE; DNA DETERMINATION; FOLLOW UP; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LIVER TOXICITY; OUTPATIENT; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; ANTI-HIV AGENTS; ANTIVIRAL AGENTS; COHORT STUDIES; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HIV INFECTIONS; HIV-1; HUMANS; ITALY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RNA, VIRAL; VIRUS REPLICATION;

EID: 34247097369     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318031d5b5     Document Type: Letter

References (14)

1. Ockenga J, Tillmann HL, Trautwein C, et al. Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value. J Hepatol. 1997;27:18-24.
2. Thio CL, Seaberg EC, Skolasky R Jr, et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet. 2002;360:1921-1926.
3. Sherman KE, Rouster SD, Chung RT, et al. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross sectional analysis of the US Adult AIDS Clinical Trials Group. Clin Infect Dis. 2002;34:831-837.
4. Bica I, McGovern B, Dhar R, et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis. 2001;32:492-497.
5. Soriano V, Sulkowski M, Bergin C, et al. Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel. AIDS. 2002;16:813-828.
6. Soriano V, Puoti M, Bonacini M, et al. Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel. AIDS. 2005;19:221-240.
7. den Brinker M, Wit FW, Wertheim-van Dillen PM, et al. Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection. AIDS. 2000;14:2895-2902.
8. Sterling RK. Triple infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus: a clinical challenge. Am J Gastroenterol. 2003;98:2130-2134.
9. Arribas JR, Gonzalez-Garcia JJ, Lorenzo A, et al. Single (B or C), dual (BC or BD) and triple (BCD) viral hepatitis in HIV-infected patients in Madrid, Spain. AIDS. 2005;19:1361-1365.
10. Bonacini M, Louie S, Bzowej N, et al. Survival in patients with HIV infection and viral hepatitis B or C: a cohort study. AIDS. 2004;18:2039-2045.
11. Servoss JC, Kitch DW, Andersen JanetW, et al. Predictors of antiretroviral-related hepatotoxicity in the Adult AIDS Clinical Trial Group (1989-1999). J Acquir Immune Defic Syndr. 2006;43:320-323.
12. Sagnelli E, Coppola N, Scolastico C, et al. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis. Hepatology. 2000;32:1106-1110.
13. Squadrito G, Orlando ME, Pollicino T, et al. Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection. Am J Gastroenterol. 2002;97:1518-1523.
14. Raimondo G, Brunetto MR, Pontisso P, et al. Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients. Hepatology. 2006;43:100-107.